Severe, intractable headache after injection with botulinum a exotoxin: report of 5 cases.

J Am Acad Dermatol

DermSurgery Associates, Houston, Texas, USA.

Published: January 2002

Background: Botulinum A exotoxin is a safe agent in common use in dermatology. Occasionally, patients receiving botulinum toxin injections report postprocedure discomfort, including headaches.

Objective: Our purpose was to estimate the rate of severe headaches occurring after injection with botulinum toxin for dermatologic indications.

Methods: We used prospective monitoring of botulinum toxin injection outcomes in a single-site, 3-dermatologist practice. There was in-office and telephone follow-up of patients experiencing severe headaches.

Results: Approximately 1% of patients (4/320) receiving botulinum A exotoxin injections may experience severe, debilitating headaches. These may persist at high intensity for 2 weeks to 1 month before gradually fading.

Conclusion: Botulinum A exotoxin injection may be associated with the development of life-altering headaches. Patients should be informed of this possibility.

Download full-text PDF

Source
http://dx.doi.org/10.1067/mjd.2001.118342DOI Listing

Publication Analysis

Top Keywords

botulinum exotoxin
16
botulinum toxin
12
injection botulinum
8
receiving botulinum
8
botulinum
7
severe
4
severe intractable
4
intractable headache
4
injection
4
headache injection
4

Similar Publications

Therapeutic Uses and Efficacy of Botulinum Toxin in Orofacial Medicine: A Dental Perspective.

Toxins (Basel)

May 2024

Clinical Oral Physiology, Department of Odontology, Faculty of Health and Medical Sciences, University of Copenhagen, DK-2200 Copenhagen, Denmark.

Botulinum neurotoxin (BoNT) is the exotoxin of , a Gram-positive, spore-forming bacterium [...

View Article and Find Full Text PDF

Background: One of the most common diseases in free-range ducks in the Mekong Delta is botulism. Botulism is a poultry disease caused by botulinum exotoxin of Clostridium botulinum.

Aim: To evaluate the prevalence of botulism in free-range ducks in the Mekong Delta and the risk of infection by determining the presence of C.

View Article and Find Full Text PDF

The Multispecialty Toxin: A Literature Review of Botulinum Toxin.

Plast Reconstr Surg Glob Open

April 2022

Department of Surgery, University of Toledo, Toledo, Ohio.

Unlabelled: Botulinum toxin (BoNT) is a potent biological exotoxin produced from . Although it was first used therapeutically to treat strabismus, its clinical role has since expanded rapidly over the years to include treatment of a variety of head and neck, gastrointestinal, urogenital, musculoskeletal, neurological, dermatological, and cosmetic disorders. The main purpose of this review is to provide a brief updated overview of the history, mechanism of action, and clinical applications of BoNT therapy across multiple medical specialties, including the most common adverse effects and recommended Botox dosages.

View Article and Find Full Text PDF

The clostridial neurotoxins (CNTs) comprise tetanus toxin (TT) and botulinum neurotoxin (BoNT [BT]) serotypes (A to G and X) and several recently identified CNT-like proteins, including BT/En and the mosquito BoNT-like toxin Pmp1. CNTs are produced as single proteins cleaved to a light chain (LC) and a heavy chain (HC) connected by an interchain disulfide bond. LC is a zinc metalloprotease (cleaving oluble -ethylmaleimide-sensitive factor ttachment protein ceptors [SNAREs]), while HC contains an N-terminal translocation domain (HCN) and a C-terminal receptor binding domain (HCC).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!